Cagrilintide Research Peptide — 1mg Lyophilized
Cagrilintide is a long-acting amylin analog under research investigation as a co-agonist therapy candidate for metabolic disorders. It is a modified analog of human amylin (IAPP — islet amyloid polypeptide) with structural modifications that extend its half-life and receptor selectivity for the amylin receptor (AMY1-3) versus calcitonin receptor.
Cagrilintide is being evaluated in combination with GLP-1 receptor agonists in published research on dual incretin/amylin receptor co-agonism. Research applications include amylin receptor binding studies, adipose tissue biology research, and neuroendocrine metabolic signaling research.
Research Specifications
- Molecular Weight: ~4,000 Da
- Purity: ≥98% (HPLC-MS)
- Storage: -20°C
⚠️ Research Use Only. Cagrilintide is a research compound, not an approved pharmaceutical. Not for human use.
